By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > ACE inhibitor > Captopril

Captopril

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|679 words

Captopril: ACE Inhibitor for High Blood Pressure and Heart Conditions

What is Captopril?

Captopril is an angiotensin-converting enzyme (ACE) inhibitor medication used primarily to treat high blood pressure and heart failure. As the first ACE inhibitor developed, it belongs to a class of medications that help relax blood vessels and reduce the workload on the heart. Captopril is available as an oral tablet and requires a prescription from a healthcare provider.

Uses

Captopril has several FDA-approved medical uses:

  • High blood pressure (hypertension): Helps lower blood pressure by relaxing blood vessels, reducing the risk of stroke, heart attack, and kidney problems
  • Heart failure: Improves heart function and reduces symptoms like shortness of breath and swelling by decreasing the heart’s workload
  • Diabetic kidney disease: Protects kidney function in people with diabetes by reducing protein loss in urine and slowing kidney damage progression
  • Post-heart attack treatment: Improves survival and reduces further heart complications when started after a heart attack
  • Left ventricular dysfunction: Helps improve heart pumping function in patients with weakened heart muscle

How it works

Captopril works by blocking the angiotensin-converting enzyme (ACE), which normally converts angiotensin I to angiotensin II, a powerful substance that narrows blood vessels and increases blood pressure. By inhibiting this enzyme, captopril prevents the formation of angiotensin II, allowing blood vessels to relax and widen. This action reduces blood pressure and decreases the amount of work the heart must do to pump blood throughout the body.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Dry cough (occurs in 10-15% of patients)
  • Dizziness or lightheadedness
  • Fatigue or weakness
  • Nausea or loss of appetite
  • Skin rash or itching
  • Altered taste sensation (metallic taste)
  • Headache
  • Low blood pressure

Serious side effects requiring immediate medical attention:

  • Angioedema (swelling of face, lips, tongue, or throat)
  • Severe allergic reactions
  • Kidney problems or decreased urination
  • High potassium levels (hyperkalemia)
  • Severe drop in blood pressure causing fainting

Warnings and precautions

  • Pregnancy: Captopril is contraindicated during pregnancy, especially in the second and third trimesters, as it can cause serious harm or death to the developing fetus
  • Kidney disease: Patients with kidney problems require careful monitoring and possible dose adjustments, as captopril can further affect kidney function
  • High potassium levels: Regular blood tests are needed to monitor potassium levels, as captopril can cause dangerous increases in blood potassium
  • Dehydration: Patients who are dehydrated, on diuretics, or have low sodium levels may experience severe blood pressure drops when starting captopril
  • Surgery: Inform your surgeon if you take captopril, as it may interact with anesthesia and cause low blood pressure during procedures

Interactions

Captopril can interact with several medications and supplements:

  • Potassium supplements and salt substitutes: May cause dangerous increases in blood potassium levels
  • Diuretics (water pills): Can cause excessive blood pressure lowering, especially when starting treatment
  • NSAIDs (ibuprofen, naproxen): May reduce captopril’s effectiveness and increase kidney damage risk
  • Lithium: Captopril can increase lithium levels, potentially causing toxicity
  • Diabetes medications: May enhance blood sugar-lowering effects, requiring dose adjustments
  • Other blood pressure medications: Can cause additive blood pressure-lowering effects
  • Allopurinol: Increases risk of serious skin reactions when combined with captopril
  • Immunosuppressants: May increase risk of blood disorders when used together

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary based on the condition being treated. For high blood pressure, the usual starting dose is 25 mg taken two to three times daily, which may be gradually increased to 50-100 mg two to three times daily as needed. For heart failure, treatment typically begins with 6.25-12.5 mg three times daily, with gradual increases up to 50 mg three times daily. Maximum daily doses generally do not exceed 450 mg. Captopril should be taken on an empty stomach, at least one hour before meals, as food can reduce its absorption. Dosage adjustments are often necessary for patients with kidney problems or elderly patients. Always follow your healthcare provider’s specific dosing instructions, as individual needs may vary significantly.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Captopril." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/captopril-2/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

CaptoprilDrug CaptoprilDrug
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK Health and Safety Authorities Issue Joint Warning on Asbestos in Consumer Products

UK regulatory authorities issue joint warning on asbestos contamination in imported consumer…

UK Releases Rabies Post-Exposure Risk Assessment Tool for Clinical Practice

The UK Department of Health and Social Care has published a standardised…

UK Sets Minimum Age of 11 for Puberty Blocker Clinical Trial in Gender-Questioning Children

The UK has set a minimum age of 11 years for children…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Enalapril

By
Prof. Giorgi Pkhakadze
01/06/2026

Fosinopril

By
Prof. Giorgi Pkhakadze
01/06/2026

Perindopril

By
Prof. Giorgi Pkhakadze
01/06/2026

Benazepril

By
Prof. Giorgi Pkhakadze
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up